Y-Intercept (HK)’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
+54,662
New +$2.31M 0.03% 798
2026
Q1
Sell
-17,241
Closed -$644K 1927
2025
Q4
$644K Buy
+17,241
New +$700K 0.01% 1152
2024
Q1
Sell
-14,986
Closed -$174K 1655
2023
Q4
$174K Buy
+14,986
New +$169K 0.02% 1027

Other funds holding PAHC

Y-Intercept (HK)'s PAHC Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 54,662 shares worth $1.72M. The stake represents 0.03% of the portfolio and ranks #798 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in PAHC as recently as Q4 2025.

Y-Intercept (HK) first reported a position in PAHC in Q4 2023 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Y-Intercept (HK) held 54,662 shares of Phibro Animal Health worth $1.72M as of Q2 2026.
  • Phibro Animal Health was a new Y-Intercept (HK) position in Q2 2026.
  • Phibro Animal Health made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #798 holding.
  • Y-Intercept (HK) first reported a position in Phibro Animal Health in Q4 2023 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.